Intraductal papillary mucinous tumors of the pancreas: Biology, diagnosis, and treatment

Oncologist

Volumn 15, Issue 12, 2010, Pages 1294-1309

  Grützmann, Robert ^a   Niedergethmann, Marco ^b   Pilarsky, Christian ^a   Klöppel, GüNter ^c   Saeger, Hans D ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cystic pancreatic tumors; Intraductal papillary mucinous neoplasm; IPMN; Subtypes; Surgery; Surveillance; Treatment

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR 2A; K RAS PROTEIN; MUCIN 1; MUCIN 2; MUCIN 5AC; PLACENTA PROTEIN 5; SMAD4 PROTEIN; TRANSCRIPTION FACTOR CDX2;

ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CIGARETTE SMOKING; COLLOID CARCINOMA; CYTOLOGY; DIABETES MELLITUS; DNA METHYLATION; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EPIGENETICS; FOLLOW UP; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTRADUCTAL CARCINOMA; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE CARCINOMA; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; NAUSEA AND VOMITING; NONHUMAN; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; PANCREATITIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR CLASSIFICATION; TUMOR LOCALIZATION; WEIGHT REDUCTION;

ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; HUMANS; PANCREATIC NEOPLASMS; PROGNOSIS;

EID: 78650978036     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0151     Document Type: Article

References (113)

1. Kosmahl M, Pauser U, Anlauf M et al. [Cystic pancreas tumors and their classification: Features old and new]. Pathologe 2005;26:22-30.
2. Ohhashi K, Murakami Y, Maruyama M et al. Four cases of mucous secreting pancreatic cancer. Prog Digest Endosc 1982;20:348-351.
3. Morohoshi T, Kanda M, Asanuma K et al. Intraductal papillary neoplasms of the pancreas. A clinicopathologic study of six patients. Cancer 1989: 64:1329-1335.
4. Klöppel G, Solcia E, Longnecker DS et al., Histological Typing of Tumours of the Exocrine Pancreas: World Health Organization International Histological Classification of Tumours, Second Edition. New York: Springer-Verlag, 1998.
5. Kosmahl M, Pauser U, Peters K et al. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: A review of 418 cases and a classification proposal. Virchows Arch 2004;445:168-178.
6. Brugge WR, Lauwers GY, Sahani D et al. Cystic neoplasms of the pancreas. N Engl J Med 2004;351:1218-1226.
7. Zamboni G, Scarpa A, Bogina G et al. Mucinous cystic tumors of the pancreas: Clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999;23:410-422.
8. Allen PJ, D'Angelica M, Gonen M et al. A selective approach to the resection of cystic lesions of the pancreas: Results from 539 consecutive patients. Ann Surg 2006;244:572-582.
9. Lee CJ, Scheiman J, Anderson MA et al. Risk of malignancy in resected cystic tumors of the pancreas ≤3 cm in size: Is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg 2008; 12:234-242.
10. Laffan TA, Horton KM, Klein AP et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-807.
11. Fukushima N, Mukai K. Pancreatic neoplasms with abundant mucus production: Emphasis on intraductal papillary-mucinous tumors and mucinous cystic tumors. Adv Anat Pathol 1999;6:65-77.
12. Su GH, Hruban RH, Bansal RK et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999;154:1835-1840.
13. Maire F, Hammel P, Terris B et al. Intraductal papillary and mucinous pancreatic tumour: A new extracolonic tumour in familial adenomatous polyposis. Gut 2002;51:446-449.
14. Poley JW, Kluijt I, Gouma DJ et al. The yield of first-time endoscopic ultrasonography in screening individuals at a high risk of developing pancreatic cancer. Am J Gastroenterol 2009;104:2175-2181.
15. Canto MI, Goggins M, Yeo CJ et al. Screening for pancreatic neoplasia in high-risk individuals: An EUS-based approach. Clin Gastroenterol Hepatol 2004;2:606-621.
16. Longnecker DS, Adsay NV, Fernandez-del Castillo C et al. Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: Interobserver agreement. Pancreas 2005; 31:344-349.
17. Hruban RH, Takaori K, Klimstra DS et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004;28:977-987.
18. Azar C, Van de Stadt J, Rickaert F et al. Intraductal papillary mucinous tumours of the pancreas. Clinical and therapeutic issues in 32 patients. Gut 1996;39:457-464.
19. Salvia R, Fernandez-del Castillo C, Bassi C et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004;239: 678-685; discussion 685-687.
20. Sohn TA, Yeo CJ, Cameron JL et al. Intraductal papillary mucinous neoplasms of the pancreas: An updated experience. Ann Surg 2004;239:788-797; discussion 797-799.
21. Sessa F, Solcia E, Capella C et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: An investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994;425:357-367.
22. Yamada M, Kozuka S, Yamao K et al. Mucin-producing tumor of the pancreas. Cancer 1991;68:159-168.
23. Adsay NV, Conlon KC, Zee SY et al. Intraductal papillary-mucinous neoplasms of the pancreas: An analysis of in situ and invasive carcinomas in 28 patients. Cancer 2002;94:62-77.
24. Adsay NV, Merati K, Basturk O et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848.
25. Furukawa T, Kloppel G, Volkan Adsay N et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: A consensus study. Virchows Arch 2005;447:794-799.
26. Luttges J, Zamboni G, Longnecker D et al. The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-948.
27. Nagata K, Horinouchi M, Saitou M et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepatobiliary Pancreat Surg 2007;14:243-254.
28. Nakamura A, Horinouchi M, Goto M et al. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: Its relationship with potential for malignancy. J Pathol 2002;197:201-210.
29. Ban S, Naitoh Y, Ogawa F et al. Intraductal papillary mucinous neoplasm (IPMN) of the gastric-type with focal nodular growth of the arborizing papillae: A case of high-grade transformation of the gastric-type IPMN. Virchows Arch 2006;449:112-116.
30. Poultsides GA, Reddy S, Cameron JL et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 2010;251:470-476.
31. Adsay NV, Adair CF, Heffess CS et al. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996;20:980-994.
32. Ban S, Naitoh Y, Mino-Kenudson M et al. Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: Its histopathologic difference between 2 major types. Am J Surg Pathol 2006;30:1561-1569.
33. Oku T, Maeda M, Wada Y et al. Intraductal oncocytic papillary neoplasm having clinical characteristics of mucinous cystic neoplasm and a benign histology. JOP 2007;8:206-213.
34. Kobari M, Egawa S, Shibuya K et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: Differences in clinical characteristics and surgical management. Arch Surg 1999;134:1131-1136.
35. Terris B, Ponsot P, Paye F et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000;24:1372-1377.
36. Detlefsen S, Sipos B, Feyerabend B et al. Pancreatic fibrosis associated with age and ductal papillary hyperplasia. Virchows Arch 2005;447:800-805.
37. Brune K, Abe T, Canto M et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006;30:1067-1076.
38. Meckler KA, Brentnall TA, Haggitt RC et al. Familial fibrocystic pancreatic atrophy with endocrine cell hyperplasia and pancreatic carcinoma. Am J Surg Pathol 2001;25:1047-1053.
39. Fritz S, Fernandez-del Castillo C, Mino-Kenudson M et al. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg 2009;249:440-447.
40. Siddiqui AD, Piperdi B. KRAS mutation in colon cancer: A marker of resistance to EGFR-I therapy. Ann Surg Oncol 2010;17:1168-1176.
41. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
42. Schönleben F, Qiu W, Bruckman KC et al. BRAF and KRAS gene mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/ IPMC) of the pancreas. Cancer Lett 2007;249:242-248.
43. Furukawa T, Fujisaki R, Yoshida Y et al. Distinct progression pathways involving the dysfunction of DUSP6/MKP-3 in pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms of the pancreas. Mod Pathol 2005;18:1034-1042.
44. House MG, Guo M, Iacobuzio-Donahue C et al. Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas. Carcinogenesis 2003;24:193-198.
45. Hong SM, Kelly D, Griffith M et al. Multiple genes are hypermethylated in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol 2008;21:1499-1507.
46. Sato N, Goggins M. Epigenetic alterations in intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg 2006;13: 280-285.
47. Sato N, Matsubayashi H, Abe T et al. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling. Clin Cancer Res 2005;11:4681-4688.
48. Bauer A, Kleeff J, Bier M et al. Identification of malignancy factors by analyzing cystic tumors of the pancreas. Pancreatology 2009;9:34-44.
49. Jung CH, Jun CB, Ro SH et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009;20: 1992-2003.
50. Habbe N, Koorstra JB, Mendell JT et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther 2009;8:340-346.
51. Ohuchida K, Mizumoto K, Fujita H et al. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: Clinical implications of mRNA levels in pancreatic juice. J Pathol 2006;210: 42-48.
52. Fritz S, Fernandez-del Castillo C, Iafrate AJ et al. Novel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms. Pancreas 2010;39:308-314.
53. Satoh K, Kanno A, Hamada S et al. Expression of Sonic hedgehog signaling pathway correlates with the tumorigenesis of intraductal papillary mucinous neoplasm of the pancreas. Oncol Rep 2008;19:1185-1190.
54. Izeradjene K, Combs C, Best M et al. Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 2007;11:229-243.
55. Siveke JT, Einwächter H, Sipos B et al. Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 2007;12:266-279.
56. Le H, Ziogas A, Rhee JM et al. Apopulation-based, descriptive analysis of malignant intraductal papillary mucinous neoplasms of the pancreas. Cancer Epidemiol Biomarkers Prev 2008;17:2737-2741.
57. Furukawa T, Takahashi T, Kobari M et al. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by threedimensional computerized mapping. Cancer 1992;70:1505-1513.
58. Tanaka M, Chari S, Adsay V et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
59. Nagai K, Doi R, Kida A et al. Intraductal papillary mucinous neoplasms of the pancreas: Clinicopathologic characteristics and long-term follow-up after resection. World J Surg 2008;32:271-278; discussion 279-280.
60. Niedergethmann M, Grützmann R, Hildenbrand R et al. Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): A 10-year experience. World J Surg 2008;32:2253-2260.
61. Sohn TA, Yeo CJ, Cameron JL et al. Intraductal papillary mucinous neoplasms of the pancreas: An increasingly recognized clinicopathologic entity. Ann Surg 2001;234:313-321; discussion 321-322.
62. D'Angelica M, Brennan MF, Suriawinata AA et al. Intraductal papillary mucinous neoplasms of the pancreas: An analysis of clinicopathologic features and outcome. Ann Surg 2004;239:400-408.
63. Murakami Y, Uemura K, Hayashidani Y et al. Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas. J Gastrointest Surg 2007;11:338-344.
64. Takahashi H, Nakamori S, Nakahira S et al. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Ann Surg Oncol 2006;13:955-960.
65. Chari ST, Yadav D, Smyrk TC et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002;123:1500-1507.
66. Wada K, Kozarek RA, Traverso LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg 2005;189:632-636; discussion 637.
67. Maire F, Hammel P, Terris B et al. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002;51:717-722.
68. Schnelldorfer T, Sarr MG, Nagorney DM et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 2008;143:639-646; discussion 646.
69. Partelli S, Fernandez-Del Castillo C, Bassi C et al. Invasive intraductal papillary mucinous carcinomas of the pancreas: Predictors of survival and the role of lymph node ratio. Ann Surg 2010;251:477-482.
70. Rodriguez JR, Salvia R, Crippa S et al. Branch-duct intraductal papillary mucinous neoplasms: Observations in 145 patients who underwent resection. Gastroenterology 2007;133:72-79; quiz 309-310.
71. Jang JY, Kim SW, Lee SE et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: When can we operate or observe? Ann Surg Oncol 2008;15:199-205.
72. Talamini G, Zamboni G, Salvia R et al. Intraductal papillary mucinous neoplasms and chronic pancreatitis. Pancreatology 2006;6:626-634.
73. Grützmann R, Bunk A, Kersting S et al. Prospective evaluation of ultrasound and colour duplex imaging for the assessment of surgical resectability of pancreatic tumours. Langenbecks Arch Surg 2003;388:392-400.
74. Itoh T, Hirooka Y, Itoh A et al. Usefulness of contrast-enhanced transabdominal ultrasonography in the diagnosis of intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 2005;100:144-152.
75. Sofuni A, Iijima H, Moriyasu F et al. Differential diagnosis of pancreatic tumors using ultrasound contrast imaging. J Gastroenterol 2005;40:518-525.
76. Nakagawa A, Yamaguchi T, Ohtsuka M et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with singledetector computed tomography and endoscopic ultrasonography. Pancreas 2009;38:131-136.
77. Baba T, Yamaguchi T, Ishihara T et al. Distinguishing benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques. Pancreas 2004;29:212-217.
78. Sedlack R, Affi A, Vazquez-Sequeiros E et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002;56:543-547.
79. Ahmad NA, Kochman ML, Brensinger C et al. Interobserver agreement among endosonographers for the diagnosis of neoplastic versus nonneoplastic pancreatic cystic lesions. Gastrointest Endosc 2003;58:59-64.
80. Gress F, Gottlieb K, Cummings O et al. Endoscopic ultrasound characteristics of mucinous cystic neoplasms of the pancreas. Am J Gastroenterol 2000;95:961-965.
81. Brugge WR. The use of EUS to diagnose cystic neoplasms of the pancreas. Gastrointest Endosc 2009;69(2 suppl):S203-S209.
82. Sahani DV, Kadavigere R, Blake M et al. Intraductal papillary mucinous neoplasm of pancreas: Multi-detector row CT with 2D curved reformations-correlation with MRCP. Radiology 2006;238:560-569.
83. Yamada Y, Mori H, Matsumoto S. Intraductal papillary mucinous neoplasms of the pancreas: Correlation of helical CT and dynamic MR imaging features with pathologic findings. Abdom Imaging 2008;33:474-481.
84. Carbognin G, Zamboni G, Pinali L et al. Branch duct IPMTs: Value of cross-sectional imaging in the assessment of biological behavior and follow-up. Abdom Imaging 2006;31:320-325.
85. Manfredi R, Graziani R, Motton M et al. Main pancreatic duct intraductal papillary mucinous neoplasms: Accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 2009;253:106-115.
86. Waters JA, Schmidt CM, Pinchot JW et al. CT vs MRCP: Optimal classification of IPMN type and extent. J Gastrointest Surg 2008;12:101-109.
87. 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: Preliminary results. J Exp Clin Cancer Res 2008;27:10.
88. Maker AV, Lee LS, Raut CP et al. Cytology from pancreatic cysts has marginal utility in surgical decision-making. Ann Surg Oncol 2008;15:3187-3192.
89. Le Borgne J, de Calan L, Partensky C. Cystadenomas and cystadenocarcinomas of the pancreas: A multiinstitutional retrospective study of 398 cases. French Surgical Association. Ann Surg 1999;230:152-161.
90. Maire F, Voitot H, Aubert A et al. Intraductal papillary mucinous neoplasms of the pancreas: Performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy. Am J Gastroenterol 2008;103:2871-2877.
91. Pais SA, Attasaranya S, Leblanc JK et al. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: Correlation with surgical histopathology. Clin Gastroenterol Hepatol 2007;5:489-495.
92. Pitman MB, Michaels PJ, Deshpande V et al. Cytological and cyst fluid analysis of small (
93. Michaels PJ, Brachtel EF, Bounds BC et al. Intraductal papillary mucinous neoplasm of the pancreas: Cytologic features predict histologic grade. Cancer 2006;108:163-173.
94. Sugiyama M, Izumisato Y, Abe N et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003;90:1244-1249.
95. Salvia R, Crippa S, Falconi M et al. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: To operate or not to operate? Gut 2007; 56:1086-1090.
96. Weinberg BM, Spiegel BM, Tomlinson JS et al. Asymptomatic pancreatic cystic neoplasms: Maximizing survival and quality of life using Markovbased clinical nomograms. Gastroenterology 2010;138:531-540.
97. Schmidt CM, White PB, Waters JA et al. Intraductal papillary mucinous neoplasms: Predictors of malignant and invasive pathology. Ann Surg 2007;246:644-651; discussion 651-654.
98. Tanno S, Nakano Y, Nishikawa T et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: Long-term follow-up results. Gut 2008;57:339-343.
99. Shimada K, Sakamoto Y, Esaki M et al. Role of medial pancreatectomy in the management of intraductal papillary mucinous neoplasms and islet cell tumors of the pancreatic neck and body. Dig Surg 2008;25:46-51.
100. Beger HG, Rau BM, Gansauge F et al. Duodenum-preserving subtotal and total pancreatic head resections for inflammatory and cystic neoplastic lesions of the pancreas. J Gastrointest Surg 2008;12:1127-1132.
101. Bendix Holme J, Jacobsen NO, Rokkjaer M et al. Total pancreatectomy in six patients with intraductal papillary mucinous tumour of the pancreas: The treatment of choice. HPB (Oxford) 2001;3:257-262.
102. Eguchi H, Ishikawa O, Ohigashi H et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer 2006;107:2567-2575.
103. Couvelard A, Sauvanet A, Kianmanesh R et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable:Aprospective evaluation. Ann Surg 2005;242:774-778; discussion 778-780.
104. Uehara H, Nakaizumi A, Ishikawa O et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 2008;57:1561-1565.
105. Yoon WJ, Ryu JK, Lee JK et al. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: Prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms. Ann Surg Oncol 2008;15:3193-3198.
106. Fasanella KE, McGrath K. Cystic lesions and intraductal neoplasms of the pancreas. Best Pract Res Clin Gastroenterol 2009;23:35-48.
107. Buscaglia JM, Giday SA, Kantsevoy SV et al. Patient and cyst-related factors for improved prediction of malignancy within cystic lesions of the pancreas. Pancreatology 2009;9:631-638.
108. Sakorafas GH, Sarr MG, van de Velde CJ et al. Intraductal papillary mucinous neoplasms of the pancreas: A surgical perspective. Surg Oncol 2005;14:155-178.
109. Sho M, Nakajima Y, Kanehiro H et al. Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas. World J Surg 1998;22:874-878.
110. Bernard P, Scoazec JY, Joubert M et al. Intraductal papillary-mucinous tumors of the pancreas: Predictive criteria of malignancy according to pathological examination of 53 cases. Arch Surg 2002;137:1274-1278.
111. Bassi C, Sarr MG, Lillemoe KD et al. Natural history of intraductal papillary mucinous neoplasms (IPMN): Current evidence and implications for management. J Gastrointest Surg 2008;12:645-650.
112. Raut CP, Cleary KR, Staerkel GA et al. Intraductal papillary mucinous neoplasms of the pancreas: Effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 2006;13:582-594.
113. Wang SE, Shyr YM, Chen TH et al. Comparison of resected and nonresected intraductal papillary mucinous neoplasms of the pancreas. World J Surg 2005;29:1650-1657.